Belantamab mafodotin
Definition: Belantamab mafodotin, sold under the brand name Blenrep, is a monoclonal antibody conjugated with a cytotoxic agent for the treatment of relapsed and refractory multiple myeloma. The most common adverse reactions include keratopathy (corneal epithelium change on eye exam), decreased visual acuity, nausea, blurred vision, pyrexia, infusion-related reactions, and fatigue. Belantamab mafodotin is a humanized IgG1κ monoclonal antibody against the B-cell maturation antigen (BCMA) conjugated with a cy... source: Wikipedia
- ID
- 896749002
- Name
- Belantamab mafodotin
- Previous ID
- 39215511000001100
- ID date
- 6 Feb 2023